NCM
BIIB icon

Northwest Capital Management’s Biogen BIIB Stock Holding History

Northwest Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-80
Closed -$17.3K – 472
2024
Q1 		$17.3K Hold
80
– – 0.01% 322
2023
Q4 		$20.7K Hold
80
– – 0.01% 299
2023
Q3 		$20.6K Hold
80
– – 0.01% 281
2023
Q2 		$22.8K Buy
+80
New +$23.8K 0.01% 280

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northwest Capital Management's BIIB Position: Q2 2024 in Review

Northwest Capital Management sold out of Biogen (BIIB) in Q2 2024, closing a stake of 80 shares — an estimated $17.3K sold.

Northwest Capital Management first reported a position in BIIB in Q2 2023 and held it in 4 quarters. The position peaked at $22.8K in Q2 2023. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Northwest Capital Management reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
  • Northwest Capital Management sold 80 Biogen shares in Q2 2024, an estimated $17.3K.
  • Northwest Capital Management first reported a position in Biogen in Q2 2023 and held it in 4 quarters.
  • Northwest Capital Management's Biogen position peaked at $22.8K in Q2 2023.
  • 943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Northwest Capital Management's 13F filing for Q2 2024, filed 9 Jul 2024.